Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2003-3-19
pubmed:abstractText
A prospective clinical study was conducted to assess the ability of the DD23 murine monoclonal antibody to enhance detection of bladder cancer in routine alcohol fixed urine cytology samples.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1078-1439
pubmed:author
pubmed:issnType
Print
pubmed:volume
7
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
185-90
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:12644214-Adolescent, pubmed-meshheading:12644214-Adult, pubmed-meshheading:12644214-Aged, pubmed-meshheading:12644214-Aged, 80 and over, pubmed-meshheading:12644214-Antibodies, Monoclonal, pubmed-meshheading:12644214-Antigens, Neoplasm, pubmed-meshheading:12644214-Biopsy, pubmed-meshheading:12644214-Carcinoma, Transitional Cell, pubmed-meshheading:12644214-Case-Control Studies, pubmed-meshheading:12644214-Cystoscopy, pubmed-meshheading:12644214-Female, pubmed-meshheading:12644214-Humans, pubmed-meshheading:12644214-Male, pubmed-meshheading:12644214-Middle Aged, pubmed-meshheading:12644214-Prospective Studies, pubmed-meshheading:12644214-Sensitivity and Specificity, pubmed-meshheading:12644214-Tumor Markers, Biological, pubmed-meshheading:12644214-Urinary Bladder Neoplasms
pubmed:articleTitle
DD23 Biomarker: a prospective clinical assessment in routine urinary cytology specimens from patients being monitored for TCC.
pubmed:affiliation
Columbia University, Urology Department, 161 Fort Washington Ave., New York, NY 10032, USA. isawczuk@humed.com
pubmed:publicationType
Journal Article, Comparative Study